Corporate Partnerships

Join the fight to save modern medicine

  • Is antibiotic resistance on your global risk register?
  • Can you show staff, customers and shareholders what you are doing about it?
  • Do you know how many of your staff suffer from a recurring or chronic infection?

Antibiotic resistance – where the bacteria that cause infections become resistant to antibiotics – is a global catastrophe that is already with us, with 10 million deaths per year predicted by 2050. Around a quarter of all infections seen in England are already resistant to at least one antibiotic.

A threat to everybody, everywhere

Modern medicine relies on antibiotics. Common infections, and nearly every medical procedure from cancer treatment to a caesarean section, would be dangerous without antibiotics.

University scientific research laboratory

“Resistance to these drugs […] places much of modern medicine in jeopardy”

Chief Medical Officer, Prof. Sir Chris Whitty

“A post-antibiotic era – in which common infections and minor injuries can kill – is a very real possibility for the 21st century.”

World Health Organisation

“We have an important role to ensure the companies in which we invest consider antimicrobials and antimicrobial resistance.”

Abigail Herron, Aviva Investors.

By coming together, we can find solutions

Our vision is a world free from death and suffering caused by drug resistant infections. As the first and only charity in the world formed specifically to tackle antibiotic resistance via research, education, and patient support, we have become a trusted voice, thought leader, and powerful advocate for the patient voice, regularly engaging with governments and media. Companies can play their part by working with us to support the innovations needed, raising awareness, and co-creating systemic change. In partnership, we can achieve this by:

Developing new treatments or alternatives to antibiotics. With our expert Science Committee, we identify quick wins like re-purposing old drugs, or high impact areas like urinary tract infections (UTIs). We support some of the brightest and best younger scientists to join the fight. In partnership, we can amplify and celebrate their achievements.

Engaging the public and professionals. We drive an agenda for change by harnessing patients’ voices to raise awareness, campaign and influence, showing patients what they can do about the pandemic that is now upon us. We also work to ensure precious antibiotics are used appropriately. With your help we can do more with students, patients, celebrities, media, and policymakers.

Providing a lifeline to people suffering. Our one-to-one Patient Support Service helps people from all walks of life, with a range of conditions. In 2022 our website had over half a million views. But in partnership we can develop the service and increase our reach into more diverse and high-risk communities.

“It would be quite a scary world to live in if the treatments we rely on for infections didn’t work anymore”

Helen, patient support service beneficiary

Watch Helen’s full video story here

Corporate responsibility: addressing both social and environmental sustainability

There are clear links between antibiotic resistance and sustainable development, climate change, and biodiversity. Rising temperatures, more densely populated cities, and more intensive farming, are drivers. Nobody is safe. But low-income communities and nations are most affected, as well as children.

Returning from the 2023 Westminster Health Forum conference, our CEO Jonathan Pearce highlighted environmental pollution, and set this as a key priority for tackling antibiotic resistance.

Because antibiotic resistance (sometimes referred to as AMR) connects to a concerning 16 out of 17 United Nations Sustainable Development Goals, by supporting our work your company is demonstrating  its commitment to a wide range of social and environmental sustainability themes.

Working with us

Our cause touches everybody, and will resonate with staff, potential staff, customers, clients, and shareholders. We offer supporter circles, partnerships, and sponsorships:

Supporter Circles

Flexible and inclusive, our Circles are designed to reflect the key role played by small and large companies in driving change. We can equip supporters with impact reports, educational content, comms, and thought leadership, allowing them to showcase values, highlight the problem and the solutions, and grow audiences. This can make it easy for supporters to lead the discussion and educate staff, customers, and clients. We can also organise VIP receptions, C-level suppers, and visits to meet scientists at top research centres, bringing you to the front line in the battle against antibiotic resistance.

Our Waksman Circle is named after the remarkable Selman Abraham Waksman who, after emigrating to the USA as a young man in the early 20th Century, discovered 18 different antibiotics including Streptomycin — the first used to cure tuberculosis. Waksman had witnessed his sister’s death from a bacterial infection as a young child and, perhaps influenced by this, left a philanthropic legacy that helped create the Institute of Microbiology at Rutgers University, New Jersey.

Our Rebstock Circle is named in recognition of Mildred Rebstock (born 1919, USA). Aged 27 and working in a male-dominated field, Rebstock was the first person to determine how to make the antibiotic chloromycetin synthetically, allowing production to be massively scaled up, helping combat typhoid fever and typhus. Despite Awards and media attention, she was unfortunately not rewarded with timely or significant promotion.

 Contact us for information.

Partnerships

Partnerships are an important way to achieve our mission. Partnerships are about more than merely funding. Companies can use their voices and audiences so that together we can raise awareness, grow our networks, and influence. In partnership we can galvanise staff, clients, and suppliers to bring about change. Key audiences or issues can be highlighted in a partnership including children, women’s health, wellbeing, diversity, or innovation. We thank and acknowledge support across our channels, and if appropriate collaborate on content, PR, and advocacy. Partners may choose to direct support to initiatives below or our other areas of work:

  • Patient Support Service
  • Medical & STEM student engagement
  • Research
Other ways we can work together include:
  • CPD staff training, or education to inspire staff to become antibiotic ambassadors.
  • Expert speakers for company events.
  • Cause-related-marketing can boost your sales and reputation. Set this up easily on our Work for Good page.
  • Payroll Giving.
  • A Charity of the Year partnership.
  • Gifts-in-kind like printing, catering, advertising space, or pro-bono expertise.
  • Staff fundraising, for example a bake sale, or sporting event. Secure popular events through our partners Run 4 Charity.
  • Order your Corporate Christmas Cards from our partners at don’t sent me a card or making a difference demonstrating your values to clients and suppliers.
  • Double your donation at no extra cost while growing your visibility, by pledging through our annual Big Give match funding campaign.
Sponsorships

We have opportunities around World AMR Awareness Week and our Annual Event and Reception.

Our funders

We are grateful to our current partners and funders for their generous support.